These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Anxiety: the pharmacological and sociological interface. Proceedings of a symposium. Englefield Green, Surrey, 29 November-1 December, 1984. Br J Clin Pract Suppl; 1985 May; 38():1-107. PubMed ID: 2862902 [No Abstract] [Full Text] [Related]
23. Evaluation of the safety and side effects of antianxiety agents. Schnabel T Am J Med; 1987 May; 82(5A):7-13. PubMed ID: 2884874 [TBL] [Abstract][Full Text] [Related]
24. Buspirone, Parkinson's disease, and the locus ceruleus. Ludwig CL; Weinberger DR; Bruno G; Gillespie M; Bakker K; LeWitt PA; Chase TN Clin Neuropharmacol; 1986; 9(4):373-8. PubMed ID: 2873889 [TBL] [Abstract][Full Text] [Related]
25. Failure of buspirone to protect against lorazepam withdrawal symptoms. Jerkovich GS; Preskorn SH JAMA; 1987 Jul; 258(2):204-5. PubMed ID: 2885432 [No Abstract] [Full Text] [Related]
27. Buspirone: a new type of anxiolytic. Dommisse CS; DeVane CL Drug Intell Clin Pharm; 1985 Sep; 19(9):624-8. PubMed ID: 2864225 [TBL] [Abstract][Full Text] [Related]
28. Buspirone: chemistry, pharmacology, and behavior. Skolnick P; Paul SM J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):40-4. PubMed ID: 6130072 [TBL] [Abstract][Full Text] [Related]
29. The side effect profile of buspirone in comparison to active controls and placebo. Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065 [TBL] [Abstract][Full Text] [Related]
32. Assessment of the abuse liability of buspirone in recreational sedative users. Cole JO; Orzack MH; Beake B; Bird M; Bar-Tal Y J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):69-75. PubMed ID: 6130076 [TBL] [Abstract][Full Text] [Related]
33. Buspirone: a non-benzodiazepine for anxiety. The Medical Letter. Conn Med; 1987 Apr; 51(4):257. PubMed ID: 3555990 [No Abstract] [Full Text] [Related]
34. Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic--proceedings from a symposium. J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):1-116. PubMed ID: 6130064 [No Abstract] [Full Text] [Related]
35. [The role of neuropeptide Y in anxiety]. Krysiak R; Obuchowicz E; Herman ZS Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605 [TBL] [Abstract][Full Text] [Related]
36. A 5-HT1A ligand with both antidepressant and anxiolytic properties. Cott JM; Kurtz NM; Robinson DS; Lancaster SP; Copp JE Psychopharmacol Bull; 1988; 24(1):164-7. PubMed ID: 2898794 [No Abstract] [Full Text] [Related]
37. Acute effects of buspirone and alcohol on psychomotor skills. Mattila MJ; Aranko K; Seppala T J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):56-61. PubMed ID: 6130074 [TBL] [Abstract][Full Text] [Related]